QA: Briacell Therapeutics Corp in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001610820_2025_Briacell_Therapeutics_Corp.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001610820, Briacell Therapeutics Corp

  xvar xval
0 AssetsCurrent 3,653,854
1 IntangibleAssetsNetIncludingGoodwill 199,796
2 PropertyPlantAndEquipmentNet 388,175
3 remainder_Assets 1,630,436
4 LiabilitiesCurrent 7,461,157
5 LiabilitiesNoncurrent 1,096,036
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,152,269
9 ResearchAndDevelopmentExpense 27,177,807
10 remainder_Expenses -28,242,472
11 remainder_Revenues 0
12 remainder_NetIncome 156,056
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 5,872,261
1 Liabilities 8,557,193
2 Expenses 5,087,604
3 Revenues 0
4 StockholdersEquity -2,684,932
5 NetIncome -4,931,548
6 ComprehensiveNetIncome -4,931,548
7 BaseVar 9,836,557
8 EconomicCapitalRatiobeforeLimitedLiability -1.49
9 EconomicCapitalRatio 1.18

Edgar->Model Mapping

Feature Distribution